These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 17361036)
1. Possible compensatory events in adult Down syndrome brain prior to the development of Alzheimer disease neuropathology: targets for nonpharmacological intervention. Head E; Lott IT; Patterson D; Doran E; Haier RJ J Alzheimers Dis; 2007 Mar; 11(1):61-76. PubMed ID: 17361036 [TBL] [Abstract][Full Text] [Related]
2. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes. García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555 [TBL] [Abstract][Full Text] [Related]
3. [Elucidating Pathogenic Mechanisms of Early-onset Alzheimer's Disease in Down Syndrome Patients]. Asai M; Kawakubo T; Mori R; Iwata N Yakugaku Zasshi; 2017; 137(7):801-805. PubMed ID: 28674290 [TBL] [Abstract][Full Text] [Related]
4. Neuronal overexpression of Alzheimer's disease and Down's syndrome associated DYRK1A/minibrain gene alters motor decline, neurodegeneration and synaptic plasticity in Drosophila. Lowe SA; Usowicz MM; Hodge JJL Neurobiol Dis; 2019 May; 125():107-114. PubMed ID: 30703437 [TBL] [Abstract][Full Text] [Related]
5. Regulator of calcineurin 1 (RCAN1) facilitates neuronal apoptosis through caspase-3 activation. Sun X; Wu Y; Chen B; Zhang Z; Zhou W; Tong Y; Yuan J; Xia K; Gronemeyer H; Flavell RA; Song W J Biol Chem; 2011 Mar; 286(11):9049-62. PubMed ID: 21216952 [TBL] [Abstract][Full Text] [Related]
6. Aging in Down Syndrome and the Development of Alzheimer's Disease Neuropathology. Head E; Lott IT; Wilcock DM; Lemere CA Curr Alzheimer Res; 2016; 13(1):18-29. PubMed ID: 26651341 [TBL] [Abstract][Full Text] [Related]
7. [Molecular Mechanism Underlying Abnormal Differentiation of Neural Progenitor Cells in the Developing Down Syndrome Brain]. Kurabayashi N; Sanada K Yakugaku Zasshi; 2017; 137(7):795-800. PubMed ID: 28674289 [TBL] [Abstract][Full Text] [Related]
8. Two key genes closely implicated with the neuropathological characteristics in Down syndrome: DYRK1A and RCAN1. Park J; Oh Y; Chung KC BMB Rep; 2009 Jan; 42(1):6-15. PubMed ID: 19192387 [TBL] [Abstract][Full Text] [Related]
9. Developmental deficits and staging of dynamics of age associated Alzheimer's disease neurodegeneration and neuronal loss in subjects with Down syndrome. Wegiel J; Flory M; Kuchna I; Nowicki K; Wegiel J; Ma SY; Zhong N; Bobrowicz TW; de Leon M; Lai F; Silverman WP; Wisniewski T Acta Neuropathol Commun; 2022 Jan; 10(1):2. PubMed ID: 34983655 [TBL] [Abstract][Full Text] [Related]
11. Role of tau protein in neuronal damage in Alzheimer's disease and Down syndrome. Cárdenas AM; Ardiles AO; Barraza N; Baéz-Matus X; Caviedes P Arch Med Res; 2012 Nov; 43(8):645-54. PubMed ID: 23142525 [TBL] [Abstract][Full Text] [Related]
12. Aberrant protein expression of transcription factors BACH1 and ERG, both encoded on chromosome 21, in brains of patients with Down syndrome and Alzheimer's disease. Shim KS; Ferrando-Miguel R; Lubec G J Neural Transm Suppl; 2003; (67):39-49. PubMed ID: 15068237 [TBL] [Abstract][Full Text] [Related]
13. Neprilysin Is Suppressed by Dual-Specificity Tyrosine-Phosphorylation Regulated Kinase 1A (DYRK1A) in Down-Syndrome-Derived Fibroblasts. Kawakubo T; Mori R; Shirotani K; Iwata N; Asai M Biol Pharm Bull; 2017; 40(3):327-333. PubMed ID: 28250274 [TBL] [Abstract][Full Text] [Related]
14. Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer's disease. Ryoo SR; Cho HJ; Lee HW; Jeong HK; Radnaabazar C; Kim YS; Kim MJ; Son MY; Seo H; Chung SH; Song WJ J Neurochem; 2008 Mar; 104(5):1333-44. PubMed ID: 18005339 [TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling in the adult Down syndrome brain. Lockstone HE; Harris LW; Swatton JE; Wayland MT; Holland AJ; Bahn S Genomics; 2007 Dec; 90(6):647-60. PubMed ID: 17950572 [TBL] [Abstract][Full Text] [Related]
16. Amyloid-β precursor protein facilitates the regulator of calcineurin 1-mediated apoptosis by downregulating proteasome subunit α type-5 and proteasome subunit β type-7. Wu Y; Deng Y; Zhang S; Luo Y; Cai F; Zhang Z; Zhou W; Li T; Song W Neurobiol Aging; 2015 Jan; 36(1):169-77. PubMed ID: 25194880 [TBL] [Abstract][Full Text] [Related]
17. The spatio-temporal and subcellular expression of the candidate Down syndrome gene Mnb/Dyrk1A in the developing mouse brain suggests distinct sequential roles in neuronal development. Hämmerle B; Elizalde C; Tejedor FJ Eur J Neurosci; 2008 Mar; 27(5):1061-74. PubMed ID: 18364031 [TBL] [Abstract][Full Text] [Related]
18. The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between beta-amyloid production and tau phosphorylation in Alzheimer disease. Kimura R; Kamino K; Yamamoto M; Nuripa A; Kida T; Kazui H; Hashimoto R; Tanaka T; Kudo T; Yamagata H; Tabara Y; Miki T; Akatsu H; Kosaka K; Funakoshi E; Nishitomi K; Sakaguchi G; Kato A; Hattori H; Uema T; Takeda M Hum Mol Genet; 2007 Jan; 16(1):15-23. PubMed ID: 17135279 [TBL] [Abstract][Full Text] [Related]
19. Reduction of chromatin assembly factor 1 p60 and C21orf2 protein, encoded on chromosome 21, in Down syndrome brain. Shim KS; Bergelson JM; Furuse M; Ovod V; Krude T; Lubec G J Neural Transm Suppl; 2003; (67):117-28. PubMed ID: 15068244 [TBL] [Abstract][Full Text] [Related]
20. Trisomy-driven overexpression of DYRK1A kinase in the brain of subjects with Down syndrome. Dowjat WK; Adayev T; Kuchna I; Nowicki K; Palminiello S; Hwang YW; Wegiel J Neurosci Lett; 2007 Feb; 413(1):77-81. PubMed ID: 17145134 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]